Kathy Zhou: Yeah, so I would say honestly, anyone with Type 2 I should have qualified that Type 2 to diabetes, which is where it's approved, would certainly probably benefit from this medication, even more so if you have something like, for example, fatty liver or cardiovascular risk or disease that's already there or kidney disease even with these medications potentially could be particularly helpful
human data is mixed Sympathetic modulation
Cranial cruciate ligament (CCL) disease the canine equivalent of a human ACL tear is among the most common orthopedic conditions, especially in medium and large breeds
Glucagon seems to regulate energy homeostasis and body weight
Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic Disorders
This could include mindfulness practices, meditation, deep breathing exercises, or hobbies that bring you joy